Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2025-08-13 00:00:00 ET · period of report 2025-08-11 · accession 0001062993-25-014296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-13 | 2025-08-11 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $4.62 | -2,173 | 672.4K | -0.3% | -$10.0K |
| D | 2025-08-13 | 2025-08-11 | ORGO | Grow Brian | Chief Commercial Off | M - OptEx | $2.47 | +4,060 | 674.5K | +0.6% | +$10.0K |
| D | 2025-08-13 | 2025-08-11 | ORGO | Grow Brian | Chief Commercial Off | M - OptEx | $0.00 | -4,060 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-08-11 | F | D | 2,173 | $4.62 | 672,377 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-08-11 | M | A | 4,060 | $2.47 | 674,550 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-08-11 | M | D | 4,060 | $0.00 | 0 | D | $2.47 · — to 2025-08-11 | 4,060 Class A Common Stock | (F1) 100% of the shares subject to the option are fully vested and exercisable. |